Vera Therapeutics, Inc. Class A Common Stock (VERA)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 339
- Market Cap
- $2.4B
About Vera Therapeutics, Inc. Class A Common Stock
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
SentiSense also tracks daily options readings for Vera Therapeutics, Inc. Class A Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Vera Therapeutics, Inc. Class A Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.